Search research articles
Contact Us
Filters
Showing results (11-20 of 147) with videos related to
Page
of 15
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
May 29, 2025
Are Diuretics a Clandestine Risk Factor for Patients With Treatment-Resistant Hypertension?
Bertram Pitt, Christopher S Wilcox
Expert Review of Cardiovascular Therapy
|
September 1, 2011
An overview of candesartan in clinical practice
Zeeshan Khawaja, Christopher S Wilcox
Antioxidants & Redox Signaling
|
March 12, 2013
Oxidative stress in hypertension: role of the kidney
Magali Araujo, Christopher S Wilcox
Journal of Cardiovascular Pharmacology
|
December 5, 2020
Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19?
Christopher S Wilcox, Bertram Pitt
Hypertension (Dallas, Tex. : 1979)
|
June 2, 2026
Management of Diuretic Induced Hypokalemia in Elderly Hypertensives
Bertram Pitt, Christopher S Wilcox
American Journal of Physiology. Heart and Circulatory Physiology
|
December 16, 2004
Focus on oxidative stress in the cardiovascular and renal systems
Christopher S Wilcox, David Gutterman
Antioxidants & Redox Signaling
|
September 22, 2006
NADPH oxidases in the kidney
Pritmohinder S Gill, Christopher S Wilcox
Current Opinion in Nephrology and Hypertension
|
December 26, 2001
What is brain nitric oxide synthase doing in the kidney?
William J Welch, Christopher S Wilcox
American Journal of Physiology. Renal Physiology
|
January 9, 2003
Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II
Christopher S Wilcox, William J Welch
American Journal of Hypertension
|
May 13, 2014
What level of sodium intake worsens renal outcomes?
Michael S Lipkowitz, Christopher S Wilcox
Page
of 15
Search research articles
Search
Showing results (11-20 of 147) with videos related to
Sort By:
Page
of 15
Hypertension (Dallas, Tex. : 1979)
|
May 29, 2025
Are Diuretics a Clandestine Risk Factor for Patients With Treatment-Resistant Hypertension?
Bertram Pitt, Christopher S Wilcox
Expert Review of Cardiovascular Therapy
|
September 1, 2011
An overview of candesartan in clinical practice
Zeeshan Khawaja, Christopher S Wilcox
Antioxidants & Redox Signaling
|
March 12, 2013
Oxidative stress in hypertension: role of the kidney
Magali Araujo, Christopher S Wilcox
Journal of Cardiovascular Pharmacology
|
December 5, 2020
Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19?
Christopher S Wilcox, Bertram Pitt
Hypertension (Dallas, Tex. : 1979)
|
June 2, 2026
Management of Diuretic Induced Hypokalemia in Elderly Hypertensives
Bertram Pitt, Christopher S Wilcox
American Journal of Physiology. Heart and Circulatory Physiology
|
December 16, 2004
Focus on oxidative stress in the cardiovascular and renal systems
Christopher S Wilcox, David Gutterman
Antioxidants & Redox Signaling
|
September 22, 2006
NADPH oxidases in the kidney
Pritmohinder S Gill, Christopher S Wilcox
Current Opinion in Nephrology and Hypertension
|
December 26, 2001
What is brain nitric oxide synthase doing in the kidney?
William J Welch, Christopher S Wilcox
American Journal of Physiology. Renal Physiology
|
January 9, 2003
Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II
Christopher S Wilcox, William J Welch
American Journal of Hypertension
|
May 13, 2014
What level of sodium intake worsens renal outcomes?
Michael S Lipkowitz, Christopher S Wilcox
Page
of 15